Montirelin

孟替瑞林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMontirelin
Drug Alias NameNS-3PS-24CG-3703CNK-602A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyrotropin releasing hormone receptor agonists
TargetsThyrotropin releasing hormone receptor
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesGrunenthal Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksKEGG